HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy.
about
Life-saving devices reach the end of life with heart failure2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theEstimating the Risks and Benefits of Implantable Cardioverter Defibrillator Generator Replacement: A Systematic Review.Hospice Use Following Implantable Cardioverter-Defibrillator Implantation in Older Patients: Results From the National Cardiovascular Data Registry.Patient preferences for deactivation of implantable cardioverter-defibrillators.Clinicians' attitudes regarding withdrawal of left ventricular assist devices in patients approaching the end of lifeEnd-of-life discontinuation of destination therapy with cardiac and ventilatory support medical devices: physician-assisted death or allowing the patient to die?HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011Engaging heart failure clinicians to increase palliative care referrals: overcoming barriers, improving techniques.Pacemaker deactivation: withdrawal of support or active ending of life?Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association.Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.A study to improve communication between clinicians and patients with advanced heart failure: methods and challenges behind the working to improve discussions about defibrillator management trial.Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.Defibrillators, deactivation, decisions, and dying.Features and outcomes of patients who underwent cardiac device deactivationDilemmas in end-stage heart failure.Cardiac implantable electrical devices: bioethics and management issues near the end of lifePatient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: American Geriatrics Society Expert Panel on the Care of Older Adults with MultimorbidityImplantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts SymposiumThe deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.Adverse experiences with implantable defibrillators in Oregon hospicesEthical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathyResynchronization: considering device-based cardiac therapy in older adults.Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study.Informed consent in cardiac resynchronization therapy: what should be said?"Just Because We Can Doesn't Mean We Should": views of nurses on deactivation of pacemakers and implantable cardioverter-defibrillators"I felt like the angel of death": role conflicts and moral distress among allied professionals employed by the US cardiovascular implantable electronic device industry.Electrophysiology and heart rhythm disorders in older adults.The use of advance directives among patients with implantable cardioverter defibrillatorsThe prevalence and contents of advance directives in patients with pacemakers.Practical and ethical considerations in the management of pacemaker and implantable cardiac defibrillator devices in terminally ill patients.Effective communication and ethical consent in decisions related to ICDs.ICD's near end of life: risk versus benefit- a review.Ethical challenges with deactivation of durable mechanical circulatory support at the end of life: left ventricular assist devices and total artificial hearts.ICD deactivation: review of literature and clinical recommendations.2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management.ANZSN renal supportive care 2013: opinion pieces [corrected].End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy.Deactivation of implantable cardioverter-defibrillators at end of life.
P2860
Q27021600-527AF95D-7FB8-4137-9681-BA68ECFA5E20Q28087002-2ED86E5F-7A40-4C03-958A-83A1483EC6F7Q30251798-AC272AE6-CB88-43E9-BB5B-08238BE59218Q31063536-3EA05C12-B33E-4480-9020-979C865D3AACQ33598449-549CA845-376A-418E-8EC5-25F36C3075C9Q33621229-F0C1B90C-B506-4CAA-9D95-7E34CA59AEE5Q33693270-35497FB4-42D2-462E-A438-05FA51AFBEDEQ33815633-6B9A4BBA-B2F7-4228-8E30-F98DD8CFDB19Q33847514-9B1D5187-C8ED-4680-8E6A-00AD0A129F19Q34164906-B2AA0913-EA29-40BA-BF1A-19057C918105Q34224601-8D3E1C9E-79E3-4AC5-BAC9-361D5CD89EF5Q34252394-6F417B66-0962-4F4E-8ACB-CC93CDB83BB9Q34381466-EE39FF79-B5C7-4A26-932A-E377061EF710Q34418562-AFFA4308-D09B-4D47-B365-893568E28A16Q34566065-55A4C462-282A-42E6-82A1-5C31031151BEQ34703695-D0C54268-1102-43CB-A003-8A666CDFD035Q35019683-03481B1B-3131-4D23-913C-073BE343B006Q35619774-F1972C72-476D-457E-98D1-6589971A6D37Q35695252-9EB9A586-468A-48D4-89EA-6FB2086F3138Q35883082-8C1723B2-B1E0-459D-9C30-8E5A524CD075Q36241346-0D7AB18B-A2DF-4653-A6BC-C92AB5227E8DQ36627456-ECC0114C-C3A8-484C-9D40-7DFE205966BFQ36697628-BAC217D3-AEFA-4675-8628-A4A6CD481020Q36773259-E04D9A7C-D5DC-4D15-9CA1-A67D4CCB74C6Q36793804-B1E51FCF-F9E4-4B76-9973-6ADFA6377CD2Q36810251-0CF8BD55-59AF-4D5B-BB9B-AE4A395F2257Q37069005-82FE9F42-A561-4950-8362-8D84280A0FD6Q37320341-DD828A6F-2268-461A-9E1D-022904659423Q37345208-3D5E76BB-BD8A-44A1-8A82-806CF8A17D6EQ37429247-4DF9E329-CE49-491C-8381-1154DF2F0B14Q37694937-7AD8FBAB-F04E-49ED-8EEC-19C8EFAEC4F8Q37699055-CDDB4A90-8D0D-4B04-96C8-57E0A6441978Q37905530-C8DC12EA-BDAE-402E-B6B4-13C2CB4E047CQ37973285-13539BD1-875A-4F5A-AC6C-8EB5252483C8Q37991491-29CCFBCF-941E-45A5-966D-C1C37CC5C072Q38014418-179FB728-E9A2-4206-8A9F-4077690DADD0Q38038846-02BF7C06-AA57-4CDE-B1F1-AC4C8596EEEFQ38099018-7DB521D8-AD2D-45E7-9019-4DB744FF0893Q38111460-B8DE4EB9-6B1C-460E-8C3B-871E2479B657Q38158220-4CFB1DCB-0012-4919-BBF0-F765C2A54958
P2860
HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HRS Expert Consensus Statement ...... uesting withdrawal of therapy.
@en
HRS Expert Consensus Statement ...... Implantable Electronic Devices
@nl
type
label
HRS Expert Consensus Statement ...... uesting withdrawal of therapy.
@en
HRS Expert Consensus Statement ...... Implantable Electronic Devices
@nl
prefLabel
HRS Expert Consensus Statement ...... uesting withdrawal of therapy.
@en
HRS Expert Consensus Statement ...... Implantable Electronic Devices
@nl
P2093
P50
P1433
P1476
HRS Expert Consensus Statement ...... uesting withdrawal of therapy.
@en
P2093
American Academy of Hospice and Palliative Medicine
American Geriatrics Society
Daniel B Kramer
David L Hayes
Debra L Wiegand
G Neal Kay
Hospice and Palliative Nurses Association
Leo Pozuelo
Margaret A Farley
Mark H Schoenfeld
P304
P356
10.1016/J.HRTHM.2010.04.033
P50
P577
2010-05-14T00:00:00Z